Navigation Links
FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Date:10/6/2010

bronchial challenge test in non-asthmatic patients with symptoms suggestive of asthma and clinically diagnosed asthmatic patients six years of age and older.  Approved for use in 19 countries, ARIDOL has been used by more than 44,000 patients, and is marketed in Australia, major European countries and Korea.  

ARIDOL is included in official international guidelines for the clinical assessment of asthma. Organizations and guidelines endorsing ARIDOL include: the International Olympic Committee Medical Commission's Independent Panel, the U.S. Asthma Management Guidelines, the Global Initiative for Asthma (GINA) Report on Global Strategy for Asthma Management and Prevention, the World Anti-Doping Agency and the Australian Asthma Management Handbook.

ARIDOL is the only dry powder bronchial challenge test approved for use in the U.S.

Indication

Mannitol, the active ingredient in ARIDOL, is a sugar alcohol indicated for the assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma.  

ARIDOL is not a stand alone test or a screening test for asthma.  Bronchial challenge testing with ARIDOL should be used only as part of a physician's overall assessment of asthma.

Important Safety Information

WARNING: RISK OF SEVERE BRONCHOSPASM

Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm.  Bronchial challenge testing with ARIDOL is for diagnostic purposes only.  Bronchial challenge testing with ARIDOL should only be conducted by trained professionals under the supervision of a physician familiar with all aspects of the bronchial challenge test and the management of acute bronchospasm. Medications (such as short acting inhaled beta-agonist) and equipment to treat severe bronchospasm must be present in the testing area.  If severe bronchospasm occurs it
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Combination Contraceptive Containing a Folate
2. U.S. FDA Approves New Oral Contraceptive That Also Raises Folate Levels
3. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
4. FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
5. FDA Approves Pediatric Use of Chemical Poisoning Treatment
6. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
7. FDA Approves Vaccines for the 2010-2011 Influenza Season
8. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
9. FDA Approves Sagent Pharmaceuticals Heparin Sodium Injection, USP
10. U.S. FDA Approves Improved Performance of Riverain Medicals OnGuard Chest X-ray Computer-Aided Detection Technology
11. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
... Qmed.com , the world,s only 100% qualified ... resource, today announced a new powerful business intelligence tool ... as part of its continuing commitment to provide users with ... "I am very pleased to announce that this new regulatory ...
... Mobility (USM) is excited to announce today that it has ... and merge its complex mobility business with USM. USM/TRS will ... Dana Mazer, ATP and his rehab team strengthens our position ... initiative in North Carolina. We are delighted to welcome their ...
Cached Medicine Technology:Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process 2Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process 3
(Date:7/10/2014)... In his latest blog post at http://www.perwickstrom.com , ... Wickstrom has listed 5 ways to follow-up without being ... get information or sometimes even just return an inquiry, ... a skill that most people don’t have,” commented Per ... dialogue moving without coming across as annoying – let ...
(Date:7/10/2014)... New York (PRWEB) July 10, 2014 ... dedicated to protecting the rights of victims injured ... has brought a lawsuit over allegations that the ... body by a power morcellator used during a ... been filed against Richard Wolf Medical Instruments Corporation ...
(Date:7/10/2014)... widespread across the United States, due in large to ... of clinical data that will become available for research ... experts in healthcare have become increasingly focused on clinical ... purpose of gleaning insights that have the potential to ... that is known as big data. ...
(Date:7/10/2014)... News) -- Adults with dyslexia are more likely to ... teenagers than people who don,t have the learning disorder, ... affects up to 10 percent of people, causes problems ... of adults with this condition said they suffered physical ... those without dyslexia. "Even after accounting for age, ...
(Date:7/10/2014)... 2014 (HealthDay News) -- Men who have a vasectomy ... a new study suggests. But the risk is ... involved with the study said more research is needed ... For the study, Harvard researchers analyzed data from ... 24 years, starting in 1986. During that time, 6,023 ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Post Lists 5 Ways to Follow-up Without Being Annoying 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3
... development of high performance HEK293, (human) production cell lines ... ... 16 Selexis SA, a Swiss-based biotechnology,company offering DNA ... discovery, development, and cGMP production of,biologics, announced today it ...
... C.V (BMV: LAB) announces the following Webcast:, What: Second ... 12:00 pm Eastern Time, ... Live over the Internet -- Simply log on to the ... above., Contact: Maria Barona of i-advize Corporate Communications, Inc., ...
... In two complementary studies, Weizmann Institute scientists have developed ... and have applied this technique to trace the history ... understand a cell,s path of descent, called a cell ... and medicine as gleaning such knowledge is key to ...
... developed a potential new treatment against cancer that attaches magnetic ... carried out of the body. The treatment, which has ... at in survival studies, is detailed online in the ... able to use magnetic nanoparticles to capture free-floating cancer cells ...
... threats like heart attack and stroke , , WEDNESDAY, July 16 ... high blood pressure -- more than 73 million adults. , ... in controlling their blood pressure. , For instance, women with ... have high cholesterol levels. They,re also less likely than men ...
... a leader in health,care quality management solutions for ... Gregory A. Buchholz to the newly created,position of ... will be,responsible for all aspects of operations at ... project management,informatics, data processing and information technology departments. ...
Cached Medicine News:Health News:Selexis Now Offering Rapid-Development of Human Cell Line With FDA Approval Pedigree 2Health News:Weizmann Institute scientists' new technique gets to the root of cancer 2Health News:Weizmann Institute scientists' new technique gets to the root of cancer 3Health News:Using magenetic nanoparticles to combat cancer 2Health News:Many Women Struggle With Uncontrolled Blood Pressure 2Health News:Many Women Struggle With Uncontrolled Blood Pressure 3Health News:Many Women Struggle With Uncontrolled Blood Pressure 4Health News:MDdatacor Names Gregory Buchholz Chief Operating Officer 2
...
Digital Ultrasonic Diagnostic Imaging System...
...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Medicine Products: